A prospective study of the antiemetic effect of palonosetron in malignant lymphoma patients treated with the CHOP regimen.

Abstract

To identify strategies for reducing emesis induced by the CHOP regimen, which includes high-dose steroids, we prospectively evaluated the efficacy of palonosetron in Japanese patients. Palonosetron was administered at a dose of 0.75 mg via intravenous injection over 30 min before chemotherapy on day 1. Patients kept diaries of chemotherapy-induced nausea and vomiting (CINV) incidence from the start of chemotherapy until 168 h afterwards, in which they documented the occurrence and severity of nausea, vomiting, anorexia, and the use of rescue medication. The primary endpoint was the overall occurrence rate of nausea, vomiting, and anorexia; these rates were 56, 12, and 62 %, respectively, including all grades. The rates and severity of symptoms tended to worsen 120-168 h after completing oral prednisolone. We defined complete response (CR) as no vomiting and no use of rescue therapy. The CR rates of post palonosetron 0.75 mg treatment in the acute (0-24 h), delayed (24-168 h), and overall phases (0-168 h) were 86, 66, and 62 %, respectively. Antiemetic strategies of CHOP regimen for day 6 and, thereafter, should be investigated.

• Authors: Yoshiharu Miyata, Kimikazu Yakushijin, Yumiko Inui, Yoshinori Imamura, Hideaki Goto, Yu Mizutani, Keiji Kurata, Seiji Kakiuchi, Yukinari Sanada, Yosuke Minami, Shinichiro Kawamoto, Katsuya Yamamoto, Mitsuhiro Ito, Ryo Tominaga, Hiroshi Gomyo, Ishikazu Mizuno, Tetsuhiko Nomura, Koichi Kitagawa, Takeshi Sugimoto, Tohru Murayama, Hiroshi Matsuoka, Hironobu Minami
• Journal: International journal of hematology (Int J Hematol) Vol. 104 Issue 6 Pg. 682-691 (Dec 2016) ISSN: 1865-3774 [Electronic] Japan
• PMID: 27612464 (Publication Type: Clinical Trial, Journal Article)

Chemical References

• Antiemetics
• Isoquinolines
• Quinuclidines
• Serotonin Antagonists
• Palonosetron
• Vincristine
• Doxorubicin
• Cyclophosphamide
• Prednisolone

Topics

• Adult
• Aged
• Antiemetics (therapeutic use)
• Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
• Cyclophosphamide (adverse effects, therapeutic use)
• Doxorubicin (adverse effects, therapeutic use)
• Female
• Humans
• Isoquinolines (therapeutic use)
• Japan (epidemiology)
• Lymphoma (drug therapy, epidemiology)
• Male
• Middle Aged
• Nausea (chemically induced, drug therapy)
• Palonosetron
• Prednisolone (adverse effects, therapeutic use)
• Prospective Studies
• Quinuclidines (therapeutic use)
• Serotonin Antagonists (therapeutic use)
• Vincristine (adverse effects, therapeutic use)
• Vomiting (chemically induced, drug therapy)
• Young Adult